Approval · Notice of Compliance 28827 · 2022
ENTROPHEN: Notice of Compliance 28827
Issued August 25, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28827
- Date
- August 25, 2022
- Company
- Pendopharm Division Of Pharmascience IncMontreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Revisions to the product labels
- Canadian reference product
- ASPIRIN 81 MG (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENTROPHEN | 02242281 | Marketed |
Medicinal ingredients
- ACETYLSALICYLIC ACID 81 MG per TAB